Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization

Molecular Biology of the Cell

Volumn 21, Issue 22, 2010, Pages 4028-4041

  Kuo, Wan Jong ^a   Digman, Michelle A ^a   Lander, Arthur D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; GROWTH FACTOR; HEPARAN SULFATE; LIGAND; RECEPTOR; RECEPTOR SUBUNIT;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CROSS LINKING; FLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; LIGAND BINDING; MOUSE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ANIMALS; BINDING SITES; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; BONE MORPHOGENETIC PROTEINS; CELL LINE; ENZYME ACTIVATION; HEPARITIN SULFATE; IMMUNOBLOTTING; LIGANDS; LUMINESCENT PROTEINS; MICE; MICROSCOPY, CONFOCAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PC12 CELLS; PHOSPHORYLATION; POLYSACCHARIDE-LYASES; PROTEIN BINDING; PROTEIN MULTIMERIZATION; RATS; SMAD PROTEINS;

EID: 78649672230     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-04-0348     Document Type: Article

References (93)

1. Akiyama, T., Kamimura, K., Firkus, C., Takeo, S., Shimmi, O., and Nakato, H. (2008). Dally regulates Dpp morphogen gradient formation by stabilizing Dpp on the cell surface. Dev. Biol. 313, 408-419.
2. Allendorph, G. P., Vale, W. W., and Choe, S. (2006). Structure of the ternary signaling complex of a TGF-beta superfamily member. Proc. Natl. Acad. Sci. USA 103, 7643-7648.
3. Aviezer, D., and Yayon, A. (1994). Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF. Proc. Natl. Acad. Sci. USA 91, 12173-12177.
4. Baeuerle, P. A., and Huttner, W. B. (1986). Chlorate-a potent inhibitor of protein sulfation in intact cells. Biochem. Biophys. Res. Commun. 141, 870-877.
5. Belenkaya, T. Y., Han, C., Yan, D., Opoka, R. J., Khodoun, M., Liu, H., and Lin, X. (2004). Drosophila Dpp morphogen movement is independent of dynamin-mediated endocytosis but regulated by the glypican members of heparan sulfate proteoglycans. Cell 119, 231-244.
6. Bellaiche, Y., The, I., and Perrimon, N. (1998). Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion. Nature 394, 85-88.
7. Bernfield, M., Gotte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., and Zako, M. (1999). Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68, 729-777.
8. Blitz, I. L., and Cho, K. W. (2009). Finding partners: how BMPs select their targets. Dev. Dyn. 238, 1321-1331.
9. Bornemann, D. J., Duncan, J. E., Staatz, W., Selleck, S., and Warrior, R. (2004). Abrogation of heparan sulfate synthesis in Drosophila disrupts the Wingless, Hedgehog and Decapentaplegic signaling pathways. Development 131, 1927-1938.
10. Capila, I., and Linhardt, R. J. (2002). Heparin-protein interactions. Ang. Chem. Int. Educ. Engl. 41, 391-412.
11. Chang, Z., Meyer, K., Rapraeger, A. C., and Friedl, A. (2000). Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ. FASEB J. 14, 137-144.
12. Damon, D. H., Halegoua, S., D'Amore, P., and Wagner, J. A. (1992). Rapid fibroblast growth factor-induced increases in protein phosphorylation and ornithine decarboxylase activity: regulation by heparin and comparison to nerve growth factor-induced increases. Exp. Cell Res. 201, 154-159.
13. de Agostini, A. I., Watkins, S. C., Slayter, H. S., Youssoufian, H., and Rosenberg, R. D. (1990). Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta. J. Cell Biol. 111, 1293-1304.
14. Digman, M. A., Dalal, R., Horwitz, A. F., and Gratton, E. (2008). Mapping the number of molecules and brightness in the laser scanning microscope. Biophys. J. 94, 2320-2332.
15. Esko, J. D., and Selleck, S. B. (2002). Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71, 435-471.
16. Fisher, M. C., Li, Y., Seghatoleslami, M. R., Dealy, C. N., and Kosher, R. A. (2006). Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation. Matrix Biol. 25, 27-39.
17. Freeman, S. D., Moore, W. M., Guiral, E. C., Holme, A. D., Turnbull, J. E., and Pownall, M. E. (2008). Extracellular regulation of developmental cell signaling by XtSulf1. Dev. Biol. 320, 436-445.
18. Frolik, C. A., Wakefield, L. M., Smith, D. M., and Sporn, M. B. (1984). Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. J. Biol. Chem. 259, 10995-11000.
19. Fujise, M., Takeo, S., Kamimura, K., Matsuo, T., Aigaki, T., Izumi, S., and Nakato, H. (2003). Dally regulates Dpp morphogen gradient formation in the Drosophila wing. Development 130, 1515-1522.
20. Gallea, S., Lallemand, F., Atfi, A., Rawadi, G., Ramez, V., Spinella-Jaegle, S., Kawai, S., Faucheu, C., Huet, L., Baron, R., and Roman-Roman, S. (2001). Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 28, 491-498.
21. Gilboa, L., Nohe, A., Geissendorfer, T., Sebald, W., Henis, Y. I., and Knaus, P. (2000). Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol. Biol. Cell 11, 1023-1035.
22. Goodger, S. J., Robinson, C. J., Murphy, K. J., Gasiunas, N., Harmer, N. J., Blundell, T. L., Pye, D. A., and Gallagher, J. T. (2008). Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms. J. Biol. Chem. 283, 13001-13008.
23. Greenwald, J., Groppe, J., Gray, P., Wiater, E., Kwiatkowski, W., Vale, W., and Choe, S. (2003). The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol. Cell 11, 605-617.
24. Haigler, H. T., Willingham, M. C., and Pastan, I. (1980). Inhibitors of 125I-epidermal growth factor internalization. Biochem. Biophys. Res. Commun. 94, 630-637.
25. Han, C., Yan, D., Belenkaya, T. Y., and Lin, X. (2005). Drosophila glypicans Dally and Dally-like shape the extracellular Wingless morphogen gradient in the wing disc. Development 132, 667-679.
26. Hashimoto, O., Nakamura, T., Shoji, H., Shimasaki, S., Hayashi, Y., and Sugino, H. (1997). A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate. J. Biol. Chem. 272, 13835-13842.
27. Hayashi, H., Ishisaki, A., and Imamura, T. (2003). Smad mediates BMP-2-induced upregulation of FGF-evoked PC12 cell differentiation. FEBS Lett. 536, 30-34.
28. Heinecke, K., Seher, A., Schmitz, W., Mueller, T. D., Sebald, W., and Nickel, J. (2009). Receptor oligomerization and beyond: a case study in bone morphogenetic proteins. BMC Biol. 7, 59.
29. Hogan, B. L. (1996). Bone morphogenetic proteins in development. Curr. Opin. Genet. Dev. 6, 432-438.
30. Ibrahimi, O. A., Zhang, F., Hrstka, S. C., Mohammadi, M., and Linhardt, R. J. (2004). Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry 43, 4724-4730.
31. Iwasaki, S., Iguchi, M., Watanabe, K., Hoshino, R., Tsujimoto, M., and Kohno, M. (1999). Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC12 cells by bone morphogenetic protein-2. J. Biol. Chem. 274, 26503-26510.
32. Iwasaki, S., Tsuruoka, N., Hattori, A., Sato, M., Tsujimoto, M., and Kohno, M. (1995). Distribution and characterization of specific cellular binding proteins for bone morphogenetic protein-2. J. Biol. Chem. 270, 5476-5482.
33. Jasuja, R., Allen, B. L., Pappano, W. N., Rapraeger, A. C., and Greenspan, D. S. (2004). Cell-surface heparan sulfate proteoglycans potentiate chordin antagonism of bone morphogenetic protein signaling and are necessary for cellular uptake of chordin. J. Biol. Chem. 279, 51289-51297.
34. Jiao, X., Billings, P. C., O'Connell, M. P., Kaplan, F. S., Shore, E. M., and Glaser, D. L. (2007). Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells. J. Biol. Chem. 282, 1080-1086.
35. Kanzaki, S., Takahashi, T., Kanno, T., Ariyoshi, W., Shinmyouzu, K., Tujisawa, T., and Nishihara, T. (2008). Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor. J. Cell. Physiol. 216, 844-850.
36. Kirkbride, K. C., Ray, B. N., and Blobe, G. C. (2005). Cell-surface co-receptors: emerging roles in signaling and human disease. Trends Biochem. Sci. 30, 611-621.
37. Kirkbride, K. C., Townsend, T. A., Bruinsma, M. W., Barnett, J. V., and Blobe, G. C. (2008). Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor. J. Biol. Chem. 283, 7628-7637.
38. Kirsch, T., Nickel, J., and Sebald, W. (2000). BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. EMBO J. 19, 3314-3324.
39. Kleeff, J., Ishiwata, T., Kumbasar, A., Friess, H., Buchler, M. W., Lander, A. D., and Korc, M. (1998). The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J. Clin. Invest. 102, 1662-1673.
40. Knaus, P., and Sebald, W. (2001). Cooperativity of binding epitopes and receptor chains in the BMP/TGFbeta superfamily. Biol. Chem. 382, 1189-1195.
41. Krufka, A., Guimond, S., and Rapraeger, A. C. (1996). Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation. Biochemistry 35, 11131-11141.
42. Lander, A. D. (1998). Proteoglycans: master regulators of molecular encounter? Matrix Biol. 17, 465-472.
43. Lander, A. D. (1999). Seeking the functions of cell surface heparan sulphate proteoglycans, in Cell Surface Proteoglycans in Signaling and Development, Human Frontiers Science Program Workshop VI, ed. A. D. Lander, H. Nakato, S. Selleck, J. Turnbull, and C. Coath. Human Frontiers Science Program, Strasbourg, Germany.
44. Lander, A. D., and Selleck, S. B. (2000). The elusive functions of proteoglycans: in vivo veritas. J. Cell Biol. 148, 227-232.
45. Larrain, J., Carey, D. J., and Brandan, E. (1998). Syndecan-1 expression inhibits myoblast differentiation through a basic fibroblast growth factor-dependent mechanism. J. Biol. Chem. 273, 32288-32296.
46. Lin, X., Buff, E. M., Perrimon, N., and Michelson, A. M. (1999). Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development 126, 3715-3723.
47. Lin, X., and Perrimon, N. (2002). Developmental roles of heparan sulfate proteoglycans in Drosophila. Glycoconj J. 19, 363-368.
48. Liu, F., Ventura, F., Doody, J., and Massague, J. (1995). Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol. Cell. Biol. 15, 3479-3486.
49. Lopez-Casillas, F., Payne, H. M., Andres, J. L., and Massague, J. (1994). Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites. J. Cell Biol. 124, 557-568.
50. Lopez-Casillas, F., Wrana, J. L., and Massague, J. (1993). Betaglycan presents ligand to the TGF beta signaling receptor. Cell 73, 1435-1444.
51. Lyon, M., Rushton, G., and Gallagher, J. T. (1997). The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific. J. Biol. Chem. 272, 18000-18006.
52. Melo, F., Carey, D. J., and Brandan, E. (1996). Extracellular matrix is required for skeletal muscle differentiation but not myogenin expression. J. Cell. Biochem. 62, 227-239.
53. Natsume, T., Tomita, S., Iemura, S., Kinto, N., Yamaguchi, A., and Ueno, N. (1997). Interaction between soluble type I receptor for bone morphogenetic protein and bone morphogenetic protein-4. J. Biol. Chem. 272, 11535-11540.
54. Nickel, J., Sebald, W., Groppe, J. C., and Mueller, T. D. (2009). Intricacies of BMP receptor assembly. Cytokine Growth Factor Rev 20, 367-377.
55. Nohe, A., Hassel, S., Ehrlich, M., Neubauer, F., Sebald, W., Henis, Y. I., and Knaus, P. (2002). The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J. Biol. Chem. 277, 5330-5338.
56. Nugent, M. A., and Edelman, E. R. (1992). Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity. Biochemistry 31, 8876-8883.
57. Ohkawara, B., Iemura, S., ten Dijke, P., and Ueno, N. (2002). Action range of BMP is defined by its N-terminal basic amino acid core. Curr. Biol. 12, 205-209.
58. Olivares, G. H., Carrasco, H., Aroca, F., Carvallo, L., Segovia, F., and Larrain, J. (2009). Syndecan-1 regulates BMP signaling and dorso-ventral patterning of the ectoderm during early Xenopus development. Dev. Biol. 329, 338-349.
59. Paine-Saunders, S., Viviano, B. L., Economides, A. N., and Saunders, S. (2002). Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients. J. Biol. Chem. 277, 2089-2096.
60. Pantoliano, M. W., Horlick, R. A., Springer, B. A., Van Dyk, D. E., Tobery, T., Wetmore, D. R., Lear, J. D., Nahapetian, A. T., Bradley, J. D., and Sisk, W. P. (1994). Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry 33, 10229-10248. (Pubitemid 24281788)
61. Paralkar, V. M., Hammonds, R. G., and Reddi, A. H. (1991). Identification and characterization of cellular binding proteins (receptors) for recombinant human bone morphogenetic protein 2B, an initiator of bone differentiation cascade. Proc. Natl. Acad. Sci. USA 88, 3397-3401.
62. Park, P. W., Reizes, O., and Bernfield, M. (2000). Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters. J. Biol. Chem. 275, 29923-29926.
63. Pellegrini, L., Burke, D. F., von Delft, F., Mulloy, B., and Blundell, T. L. (2000). Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 407, 1029-1034.
64. Perrimon, N., and Bernfield, M. (2000). Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404, 725-728. (Pubitemid 30212391)
65. Plotnikov, A. N., Schlessinger, J., Hubbard, S. R., and Mohammadi, M. (1999). Structural basis for FGF receptor dimerization and activation. Cell 98, 641-650.
66. Powell, A. K., Yates, E. A., Fernig, D. G., and Turnbull, J. E. (2004). Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches. Glycobiology 14, 17R-30R.
67. Rapraeger, A. C., Krufka, A., and Olwin, B. B. (1991). Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252, 1705-1708.
68. Roghani, M., and Moscatelli, D. (1992). Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J. Biol. Chem. 267, 22156-22162.
69. Rosenberg, R. D., Shworak, N. W., Liu, J., Schwartz, J. J., and Zhang, L. (1997). Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J. Clin. Invest. 100, S67-75.
70. Ruppert, R., Hoffmann, E., and Sebald, W. (1996). Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur. J. Biochem. 237, 295-302.
71. Sampath, T. K., Muthukumaran, N., and Reddi, A. H. (1987). Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. Proc. Natl. Acad. Sci. USA 84, 7109-7113.
72. Schlessinger, J., Plotnikov, A. N., Ibrahimi, O. A., Eliseenkova, A. V., Yeh, B. K., Yayon, A., Linhardt, R. J., and Mohammadi, M. (2000). Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell 6, 743-750.
73. Serpe, M., Umulis, D., Ralston, A., Chen, J., Olson, D. J., Avanesov, A., Othmer, H., O'Connor, M. B., and Blair, S. S. (2008). The BMP-binding protein Crossveinless 2 is a short-range, concentration-dependent, biphasic modulator of BMP signaling in Drosophila. Dev. Cell 14, 940-953.
74. Shi, Y., and Massague, J. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700.
75. Sperinde, G. V., and Nugent, M. A. (1998). Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells. Biochemistry 37, 13153-13164.
76. Sperinde, G. V., and Nugent, M. A. (2000). Mechanisms of fibroblast growth factor 2 intracellular processing: a kinetic analysis of the role of heparan sulfate proteoglycans. Biochemistry 39, 3788-3796.
77. Spivak-Kroizman, T., Lemmon, M. A., Dikic, I., Ladbury, J. E., Pinchasi, D., Huang, J., Jaye, M., Crumley, G., Schlessinger, J., and Lax, I. (1994). Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79, 1015-1024.
78. Szabo, A., Stolz, L., and Granzow, R. (1995). Surface plasmon resonance and its use in biomolecular interaction analysis (BIA). Curr. Opin. Struct. Biol. 5, 699-705.
79. Takada, T., Katagiri, T., Ifuku, M., Morimura, N., Kobayashi, M., Hasegawa, K., Ogamo, A., and Kamijo, R. (2003). Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J. Biol. Chem. 278, 43229-43235.
80. ten Dijke, P., Miyazono, K., and Heldin, C. H. (1996). Signaling via heterooligomeric complexes of type I and type II serine/threonine kinase receptors. Curr. Opin. Cell Biol. 8, 139-145.
81. ten Dijke, P., Yamashita, H., Sampath, T. K., Reddi, A. H., Estevez, M., Riddle, D. L., Ichijo, H., Heldin, C. H., and Miyazono, K. (1994). Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269, 16985-16988.
82. Tsuda, M. et al. (1999). The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila. Nature 400, 276-280.
83. Turnbull, J., Powell, A., and Guimond, S. (2001). Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol. 11, 75-82.
84. Vinals, F., Lopez-Rovira, T., Rosa, J. L., and Ventura, F. (2002). Inhibition of PI3K/p70 S6K and p38 MAPK cascades increases osteoblastic differentiation induced by BMP-2. FEBS Lett. 510, 99-104.
85. Viviano, B. L., Paine-Saunders, S., Gasiunas, N., Gallagher, J., and Saunders, S. (2004). Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist Noggin. J. Biol. Chem. 279, 5604-5611.
86. Weber, D., Kotzsch, A., Nickel, J., Harth, S., Seher, A., Mueller, U., Sebald, W., and Mueller, T. D. (2007). A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor. BMC Struct. Biol. 7, 6.
87. Wendler, J., Vallejo, L. F., Rinas, U., and Bilitewski, U. (2005). Application of an SPR-based receptor assay for the determination of biologically active recombinant bone morphogenetic protein-2. Anal. Bioanal. Chem. 381, 1056-1064.
88. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. (1994). Mechanism of activation of the TGF-beta receptor. Nature 370, 341-347.
89. Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., and Ornitz, D. M. (1991). Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848.
90. Yoon, B. S., and Lyons, K. M. (2004). Multiple functions of BMPs in chondrogenesis. J. Cell. Biochem. 93, 93-103.
91. Zhao, B., Katagiri, T., Toyoda, H., Takada, T., Yanai, T., Fukuda, T., Chung, U. I., Koike, T., Takaoka, K., and Kamijo, R. (2006). Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J. Biol. Chem. 281, 23246-23253.
92. Zioncheck, T. F., Richardson, L., Liu, J., Chang, L., King, K. L., Bennett, G. L., Fugedi, P., Chamow, S. M., Schwall, R. H., and Stack, R. J. (1995). Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity. J. Biol. Chem. 270, 16871-16878.
93. Zuber, M. X., Strittmatter, S. M., and Fishman, M. C. (1989). A membrane-targeting signal in the amino terminus of the neuronal protein GAP-43. Nature 341, 345-348.